Literature DB >> 19125866

Molecular responses of the Ts65Dn and Ts1Cje mouse models of Down syndrome to MK-801.

A Siddiqui1, T Lacroix, M R Stasko, J J Scott-McKean, A C S Costa, K J Gardiner.   

Abstract

Down syndrome (DS), caused by trisomy of human chromosome 21 (chr21), is the most common genetic cause of intellectual disability. The Ts65Dn mouse model of DS is trisomic for orthologs of 94 chr21-encoded, confirmed protein-coding genes and displays a number of behavioral deficits. Recently, Ts65Dn mice were shown to be hypersensitive to the locomotor stimulatory effects of the high-affinity N-methyl-d-aspartate (NMDA) receptor (NMDAR) channel blocker, MK-801. This is consistent with the functions of several chr21 proteins that are predicted directly or indirectly to impact NMDAR function or NMDAR-mediated signaling. In this study, we show that a second mouse model of DS, the Ts1Cje, which is trisomic for 70 protein-coding genes, is also hypersensitive to MK-801. To investigate the molecular basis for the responses to MK-801, we have measured levels of a subset of chr21 and phosphorylated non-chr21 proteins, in the cortex and hippocampus of Ts65Dn and Ts1Cje mice and euploid controls, with and without treatment with MK-801. We show that in euploid mice, the chr21-encoded proteins, TIAM1 and DYRK1A, and phosphorylation of AKT, ERK1/2 and the transcription factor ELK are involved in the MK-801 response. However, in both Ts65Dn and Ts1Cje mice, levels of phosphorylation are constitutively elevated in naïve, unstimulated mice, and the MK-801-induced changes in TIAM1 and DYRK1A and in phosphorylation are either absent or abnormal, with both genotype and brain-region-specific patterns. These results emphasize the complexities of the pathway perturbations that arise with segmental trisomy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19125866      PMCID: PMC2677016          DOI: 10.1111/j.1601-183X.2008.00428.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  64 in total

1.  Alterations of central noradrenergic transmission in Ts65Dn mouse, a model for Down syndrome.

Authors:  M Dierssen; I F Vallina; C Baamonde; S García-Calatayud; M A Lumbreras; J Flórez
Journal:  Brain Res       Date:  1997-02-28       Impact factor: 3.252

2.  A new role for IQ motif proteins in regulating calmodulin function.

Authors:  John A Putkey; Quinn Kleerekoper; Tara R Gaertner; M Neal Waxham
Journal:  J Biol Chem       Date:  2003-10-09       Impact factor: 5.157

Review 3.  Building protein interaction maps for Down's syndrome.

Authors:  Katheleen Gardiner; Muriel T Davisson; Linda S Crnic
Journal:  Brief Funct Genomic Proteomic       Date:  2004-08

4.  Focused microwave irradiation of the brain preserves in vivo protein phosphorylation: comparison with other methods of sacrifice and analysis of multiple phosphoproteins.

Authors:  James P O'Callaghan; Krishnan Sriram
Journal:  J Neurosci Methods       Date:  2004-05-30       Impact factor: 2.390

5.  Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities.

Authors:  H Sago; E J Carlson; D J Smith; J Kilbridge; E M Rubin; W C Mobley; C J Epstein; T T Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

6.  The calcium/calmodulin-dependent protein phosphatase calcineurin is the major Elk-1 phosphatase.

Authors:  T Sugimoto; S Stewart; K L Guan
Journal:  J Biol Chem       Date:  1997-11-21       Impact factor: 5.157

7.  Quantitative PCR genotyping assay for the Ts65Dn mouse model of Down syndrome.

Authors:  Dong P Liu; Cecilia Schmidt; Timothy Billings; Muriel T Davisson
Journal:  Biotechniques       Date:  2003-12       Impact factor: 1.993

8.  Inositol phospholipids regulate the guanine-nucleotide-exchange factor Tiam1 by facilitating its binding to the plasma membrane and regulating GDP/GTP exchange on Rac1.

Authors:  Ian N Fleming; Ian H Batty; Alan R Prescott; Alex Gray; Gursant S Kular; Hazel Stewart; C Peter Downes
Journal:  Biochem J       Date:  2004-09-15       Impact factor: 3.857

9.  Glial-derived S100b protein selectively inhibits recombinant beta protein kinase C (PKC) phosphorylation of neuron-specific protein F1/GAP43.

Authors:  F S Sheu; E C Azmitia; D R Marshak; P J Parker; A Routtenberg
Journal:  Brain Res Mol Brain Res       Date:  1994-01

Review 10.  Segmental trisomy as a mouse model for Down syndrome.

Authors:  M T Davisson; C Schmidt; R H Reeves; N G Irving; E C Akeson; B S Harris; R T Bronson
Journal:  Prog Clin Biol Res       Date:  1993
View more
  25 in total

Review 1.  Prospects for improving brain function in individuals with Down syndrome.

Authors:  Alberto C S Costa; Jonah J Scott-McKean
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

2.  The Rac-GEF Tiam1 Promotes Dendrite and Synapse Stabilization of Dentate Granule Cells and Restricts Hippocampal-Dependent Memory Functions.

Authors:  Jinxuan Cheng; Federico Scala; Francisco A Blanco; Sanyong Niu; Karen Firozi; Laura Keehan; Shalaka Mulherkar; Emmanouil Froudarakis; Lingyong Li; Joseph G Duman; Xiaolong Jiang; Kimberley F Tolias
Journal:  J Neurosci       Date:  2020-12-16       Impact factor: 6.167

3.  Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: implications for Parkinson's disease.

Authors:  Almas Siddiqui; Shankar J Chinta; Jyothi K Mallajosyula; Subramanian Rajagopolan; Ingrid Hanson; Anand Rane; Simon Melov; Julie K Andersen
Journal:  Free Radic Biol Med       Date:  2012-06-15       Impact factor: 7.376

4.  Exaggerated NMDA mediated LTD in a mouse model of Down syndrome and pharmacological rescuing by memantine.

Authors:  Jonah J Scott-McKean; Alberto C S Costa
Journal:  Learn Mem       Date:  2011-11-18       Impact factor: 2.460

5.  Effects of a Tripeptide on Mitogen-Activated Protein Kinase and Glycogen Synthase Kinase Activation in a Cell Line Derived from the Foetal Hippocampus of a Trisomy 16 Mouse: an Animal Model of Down Syndrome.

Authors:  Tushar Arora; Pablo Caviedes; Shiv Kumar Sharma
Journal:  Neurotox Res       Date:  2019-12-04       Impact factor: 3.911

Review 6.  Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics.

Authors:  Marzia Perluigi; Fabio Di Domenico; D Allan Buttterfield
Journal:  Proteomics Clin Appl       Date:  2014-02       Impact factor: 3.494

Review 7.  Molecular basis of pharmacotherapies for cognition in Down syndrome.

Authors:  Katheleen J Gardiner
Journal:  Trends Pharmacol Sci       Date:  2009-12-04       Impact factor: 14.819

8.  Normal protein composition of synapses in Ts65Dn mice: a mouse model of Down syndrome.

Authors:  Fabian Fernandez; Jonathan C Trinidad; Martina Blank; Dong-Dong Feng; Alma L Burlingame; Craig C Garner
Journal:  J Neurochem       Date:  2009-04-22       Impact factor: 5.372

9.  Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain.

Authors:  Marzia Perluigi; Gilda Pupo; Antonella Tramutola; Chiara Cini; Raffaella Coccia; Eugenio Barone; Elizabeth Head; D Allan Butterfield; Fabio Di Domenico
Journal:  Biochim Biophys Acta       Date:  2014-04-13

Review 10.  Molecular genetic analysis of Down syndrome.

Authors:  David Patterson
Journal:  Hum Genet       Date:  2009-06-13       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.